Sugi Predict

Sugi Predict / Compounds / SCHEMBL353815

SCHEMBL353815

SCHEMBL353815

CN(Cc1nsc(NC(=O)NCc2cccc(F)c2)n1)C(=O)c1cc(S(N)(=O)=O)cn1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 2/20 0.42
▸ ROCK1 Q13464 2/20 0.42
▸ NAMPT P43490 4/20 0.41
▸ NPC1 O15118 1/20 0.39
▸ ATG4B Q9Y4P1 1/20 0.38
▸ AURKA O14965 2/20 0.37
▸ AURKB Q96GD4 2/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ EPHX2 P34913 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ LIMK2 P53671 1/20 0.35
▸ SGK1 O00141 1/20 0.35
▸ AKT1 P31749 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ LIMK1 P53667 1/20 0.35
▸ TNK2 Q07912 1/20 0.35
▸ DMPK Q09013 1/20 0.35
▸ MYLK Q15746 1/20 0.35
▸ CDC42BPA Q5VT25 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19119519 0.89 ROCK2 (0.40) ROCK2ROCK1NAMPTNPC1ATG4B
SCHEMBL354480 0.88 ROCK1 (0.47) ROCK2ROCK1NAMPTATG4BSGK1
SCHEMBL353247 0.84 KMT2A (0.46) ROCK2ROCK1NAMPTNPC1ATG4B
SCHEMBL352587 0.83 KLKB1 (0.31) ALDH1A1
SCHEMBL353291 0.80 ROCK2 (0.48) ROCK2ROCK1NAMPTNPC1ATG4B
SCHEMBL352804 0.79 ROCK2 (0.48) ROCK2ROCK1NAMPTNPC1ATG4B
SCHEMBL353153 0.79 ROCK2 (0.43) ROCK2ROCK1NAMPTNPC1ATG4B
SCHEMBL352803 0.78 ROCK2 (0.44) ROCK2ROCK1NAMPTNPC1ATG4B
Cyclohexane SCHEMBL19119453 0.78 ROCK2 (0.50) ROCK2ROCK1NAMPTNPC1ATG4B
Cyclopentane SCHEMBL19119283 0.78 ROCK2 (0.50) ROCK2ROCK1NAMPTNPC1ATG4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 — — US claimed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 — — US claimed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 — — EP claimed
WO-2009015208-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 — — WO claimed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 — — US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA ROCK2 4626/4885ROCK1 4747/4885NAMPT 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.